Related Experiment Video

Updated: Apr 17, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.8K

MDMX exerts its oncogenic activity via suppression of retinoblastoma protein

H Zhang1, L Hu1, W Qiu2

  • 1Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resource and Eco-Environment, Ministry of Education, College of Life Sciences and State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.

Oncogene
|February 24, 2015
PubMed

Insights

MDMX protein promotes cancer by degrading the retinoblastoma protein (RB) in an MDM2-dependent manner. Inhibiting MDMX or MDM2 may offer new cancer therapies by restoring RB levels.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Retinoblastoma protein (RB) inactivation is crucial in human cancer development.
  • MDM2 is a key negative regulator of p53 and promotes RB degradation.
  • MDMX inhibits p53 but lacks E3 ligase activity.

Purpose of the Study:

  • To investigate the role of MDMX in retinoblastoma protein (RB) regulation.
  • To elucidate the mechanism by which MDMX influences RB degradation.
  • To assess the therapeutic potential of targeting MDMX in cancer.

Main Methods:

  • Investigated MDMX-RB interaction using binding assays.
  • Assessed MDM2-RB interaction enhancement by MDMX.
  • Utilized MDMX silencing and RB knockdown in cell culture.
  • Evaluated tumor growth in xenograft models after MDMX ablation.

Main Results:

  • MDMX binds to RB's C-pocket and enhances MDM2-RB interaction, promoting RB degradation.
  • MDMX silencing leads to RB accumulation, cell cycle arrest, and senescence.
  • RB knockdown reverses MDMX silencing-induced phenotypes.
  • MDMX ablation significantly retards xenograft tumor growth with increased RB levels.

Conclusions:

  • MDMX promotes oncogenesis by suppressing RB levels in an MDM2-dependent manner.
  • MDMX's interaction with RB and MDM2 is critical for its function.
  • MDM2 and MDMX represent potential chemotherapeutic targets for cancer treatment.

More Related Videos

Reconstruct Human Retinoblastoma In Vitro06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

1.9K
Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.7K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K